Axa’s US IPO prices well below expectations
The sale of one of Axa’s US businesses, which will be used to fund the French insurance giant’s purchase of XL Group, is likely to bring in far less than it initially expected.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below